Collector’s Guide: Arboliva ex (Destined Rivals #23)

Arboliva ex Collector’s Guide

Character Intro

Arboliva ex is a Double Rare card from the Destined Rivals set, numbered 23. With a robust 310 HP and the tactical Aroma Shot attack, it’s a formidable presence in play and a standout for collectors.

Quick Facts

set_name release_date number rarity hp illustrator
Destined Rivals 23 Double Rare 310 PLANETA Tsuji
  • Type: Grass
  • Stage: Stage 2, ex (evolves from Dolliv)
  • Retreat Cost: 2
  • Weakness: Fire ×2
  • Resistance: None
  • Rules: Pokémon ex rule applies—when knocked out, opponent takes 2 Prize cards.

Key Printings

This exact printing of Arboliva ex appears in the Scarlet & Violet series set “Destined Rivals” with the set code sv10-23. It is a Double Rare card, notable for its high HP and two powerful attacks:
– Oil Salvo: deals 20 damage six times, ignoring Weakness and Resistance
– Aroma Shot: deals 160 damage and heals all Special Conditions from Arboliva ex

Variants & Identifiers

There are no known print variants for this card. Key identifiers include the card number 23 in the Destined Rivals set, the illustrator PLANETA Tsuji, and the regulation mark I.

Legality & Play Notes

Legality: unknown
This card is not currently legal in Standard, Expanded, or Unlimited formats. The Pokémon ex rule applies, meaning if Arboliva ex is Knocked Out, your opponent takes 2 Prize cards.

Care & Storage Tips

To protect the artwork and condition, store Arboliva ex in a sleeve, away from direct sunlight and moisture. Avoid bending or scratching to preserve value and playability.

Set-by-Set Micro-summaries

  • Destined Rivals (sv10): Introduces Arboliva ex as a powerful Grass-type Stage 2 ex Pokémon with high HP and unique attacks, adding strategic depth to the set’s roster.

Catch This Card on eBay

Search live listings for Pokemon TCG Arboliva ex Destined Rivals.


Browse eBay listings

This section contains affiliate links. If you buy through them, we may earn a commission at no extra cost to you.

Comments

Leave a Reply